corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 82 of 206 pages ‹ First  < 80 81 82 83 84 >  Last ›

HSL10383
Rubin R.
FDA scientist says she was reprimanded for warning
USA Today 2007 Jun 10
http://www.usatoday.com/news/health/2007-06-10-fda-insider_N.htm

HSL10405
Egan C.
Crackdown on children's ads
The Age (Melbourne) 2007 Jun 10
http://www.theage.com.au/news/national/food-giants-axe-fat-ads/2007/06/09/1181089398393.html

HSL10384
Philip M.
Nearly half of children in Crown care are medicated
The Globe and Mail (Toronto) 2007 Jun 9
http://www.theglobeandmail.com/servlet/story/RTGAM.20070609.wdrugs09/EmailBNStory/National/home

HSL10385
Henry D.
Patients the losers and makers the winners in PBS tinkering
The Australian 2007 Jun 9
http://www.theaustralian.news.com.au/story/0,20867,21872525-23289,00.html

HSL10583
Kontominas B.
Food firms accused of pushing toddler milk
Sydney Morning Herald 2007 Jun 9
http://www.smh.com.au/news/national/food-firms-accused-of-pushing-toddler-milk/2007/06/08/1181089328745.html

HSL10769
Stone R.
Mongkol na Songkhla interview. Thai health minister defends controversial drug-patent policy.
Science 2007 Jun 8;316:(5830):1408
http://www.sciencemag.org/cgi/content/full/316/5830/1408

HSL10403
Saul S.
Doctor Says He Was Assailed for Challenging Drug’s Safety
New York Times 2007 Jun 7
http://www.nytimes.com/2007/06/07/health/07buse.html

HSL10404
Harris G.
F.D.A. Issues Strictest Warning on Diabetes Drugs
New York Times 2007 Jun 7
http://www.nytimes.com/2007/06/07/health/07drug.html

HSL10559
Domingo AF, Salvana EM.
Solicitation of deceased and living organ donors.
N Engl J Med 2007 Jun 7;356:(23):2427-9
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17563925&dopt=Abstract

HSL10561
Spital A.
Solicitation of deceased and living organ donors.
N Engl J Med 2007 Jun 7;356:(23):2427-9
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17554130&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL10570
Friedman RA, Leon AC.
Expanding the black box - depression, antidepressants, and the risk of suicide.
N Engl J Med 2007 Jun 7;356:(23):2343-6
http://content.nejm.org/cgi/content/full/356/23/2343

HSL10810
Bad execution.
Nature 2007 Jun 7;447:(7145):613-4
http://www.nature.com/doifinder/10.1038/447613b

HSL10387
Graham M.
Prescribe Me! A Treasure Trove of Psychiatric Drug Swag
Wired 2007 Jun 6
http://www.wired.com/medtech/drugs/news/2007/06/drugswag

HSL10395
Saul S, Harris G.
Diabetes Drug Still Has Heart Risks, Doctors Warn
New York Times 2007 Jun 6
http://www.nytimes.com/2007/06/06/health/06fda.html?pagewanted=1&_r=1

HSL10396
Story L.
On Avandia, a Niche Strategy Now Under Stress
New York Times 2007 Jun 6Media & Advertising
http://www.nytimes.com/2007/06/06/business/media/06adco.html?pagewanted=1

HSL10397
Boseley S.
The truth about HRT
The Guardian 2007 Jun 6
http://society.guardian.co.uk/health/story/0,,2096553,00.html

HSL10398
Simons J.
A Big Pharma whistleblower blogs on drugs
Fortune Magazine 2007 Jun 6
http://money.cnn.com/magazines/fortune/fortune_archive/2007/06/11/100061497/index.htm?source=yahoo_quote

HSL10400
Goldstein S.
Glaxo defends Avandia before Congress hearing
MarketWatch 2007 Jun 6
http://www.marketwatch.com/news/story/glaxo-defends-diabetes-drug-ahead/story.aspx?guid=%7B81B55457%2D4734%2D4AD2%2DBA36%2D349FCF601EDA%7D&siteid=yhoof

HSL10402
Perrone M.
Avandia to Carry Stronger Warning Label
Associated Press 2007 Jun 6
http://biz.yahoo.com/ap/070606/diabetes_drug_congress.html?.v=2

HSL10406
Jordan GE.
Fast track Abilify
The New Jerey Star-Ledger 2007 Jun 6
http://www.nj.com/starledger/stories/index.ssf?/base/business-0/1181114203185750.xml&coll=1&thispage=1

HSL10442
Rosiglitazone defence unconvincing
Prescribing Advice for GPs: An NHS Prescribing Advisers’ Blog 2007 Jun 6
http://www.prescriber.org.uk/?p=378

HSL10392
Blum J.
Glaxo's Avandia Fuels Arguments for Tougher Drug Laws
Bloomberg News 2007 Jun 5
http://www.bloomberg.com/apps/news?pid=20601202&sid=aEoQ2_S.ndTY&refer=healthcare

HSL10394
Nigeria sues drugs giant Pfizer
BBC News 2007 Jun 5
http://news.bbc.co.uk/2/hi/africa/6719141.stm

HSL10401
Marchione M.
Newest Avandia Study Not Reassuring
Associated Press 2007 Jun 5
http://biz.yahoo.com/ap/070605/diabetes_drug_risks.html?.v=6

HSL10408
Bero L, Oostvogel F, Bacchetti P, Lee K.
Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others
PLoS Medicine 2007 Jun 5;4:(6):e184
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040184

HSL10827
Attaran A.
A tragically naive Canadian law for tragically neglected global health.
CMAJ 2007 Jun 5;176:(12):1726-7
http://www.cmaj.ca/cgi/content/full/176/12/1726

HSL10345
Thomaselli R.
Big Pharma Doesn't Like How It Looks on YouTube
Advertising Age 2007 Jun 4
http://adage.com/article?article_id=117070

HSL10346
Larkin C.
New U.S. Panel to Tell Public of Drug, Device Risks
Bloomberg News 2007 Jun 4
http://www.bloomberg.com/apps/news?pid=20601202&sid=aZq13_5Ns1bw&refer=healthcare

HSL10347
Adigun B.
Nigeria Files New Suit Against Pfizer
Associated Press 2007 Jun 4
http://biz.yahoo.com/ap/070604/nigeria_pfizer.html?.v=1

HSL10566
FDA Announces New Advisory Committee to Address Risk Communication
PharmaLive 2007 Jun 4
http://pharmalive.com/news/index.cfm?articleID=448240&categoryid=9&newsletter=1

HSL10593
Cancer Experts Threatened After Opposing Drug
New York Times 2007 Jun 4
http://www.nytimes.com/2007/06/04/health/04drug.html?ex=1182398400&en=06eedb7d226bb004&ei=5070

HSL10342
Fanning E, Lumb K
The Stilnox dilemma
Sunday programme, ninemsn (Australia) 2007 Jun 3
http://sunday.ninemsn.com.au/sunday/cover_stories/article_2217.asp

HSL10343
Harris G, Roberts J
After Sanctions, Doctors Get Drug Company Pay
New York Times 2007 Jun 3
http://www.nytimes.com/2007/06/03/health/03docs.html?pagewanted=1&_r=1

HSL10344
Mares P, Panichi J.
Owning the PBS
The National Interest, ABC Radio National (Australia) 2007 Jun 3
http://www.abc.net.au/rn/nationalinterest/stories/2007/1940042.htm

HSL10350
Emery C.
Drugmakers woo med students
Baltimore Sun 2007 Jun 3
http://www.baltimoresun.com/news/education/bal-te.hs.medschool03jun03,0,3878457.story?page=1&coll=bal-education-top

HSL10316
Mabey D.
Improving health for the world's poor
BMJ 2007 Jun 2;334:(7604):1126
http://www.bmj.com/cgi/content/full/334/7604/1126

HSL10321
Ford S.
Political illiteracy: Many, but not all
BMJ 2007 Jun 2;334:(7604):1128
http://www.bmj.com/cgi/content/short/334/7604/1128-c?etoc

HSL10322
Glusker A.
Assembly gets into wrangle over wording of junk food warning
BMJ 2007 Jun 2;334:(7604):1130
http://www.bmj.com/cgi/content/full/334/7604/1130

HSL10323
Butcher J.
UK will lose clinical trials if electronic records system is delayed, ABPI warns
BMJ 2007 Jun 2;334:(7604):1132
http://www.bmj.com/cgi/content/full/334/7604/1132-a

HSL10341
Cresswell A.
Alert over sleep drug ignored
The Australian 2007 Jun 2
http://www.theaustralian.news.com.au/story/0,20867,21834708-23289,00.html

HSL10349
Is It Philanthropy or Marketing?
Philanthropy News Digest 2007 Jun 2
http://foundationcenter.org/pnd/news/story.jhtml;jsessionid=BITARZFWKQUUVTQRSI4CGXD5AAAACI2F?id=179400031

HSL10399
Saul S.
Doctor Says Drug Maker Tried to Quash His Criticism of Avandia
New York Times 2007 Jun 2
http://www.nytimes.com/2007/06/02/business/02drug.html?pagewanted=2&ei=5070&en=c08d557ee678eb11&ex=1181707200

HSL10562
Epstein M.
Clinical trials in the developing world.
Lancet 2007 Jun 2;369:(9576):1859
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(07)60846-0

HSL10055
McFadden DW, Calvario E, Graves C.
The Devil Is in the Details: The Pharmaceutical Industry's Use of Gifts to Physicians as Marketing Strategy.
J Surg Res 2007 Jun 1;140:(1):1-5
http://linkinghub.elsevier.com/retrieve/pii/S0022-4804(06)00533-6

HSL10205
Pinto SL, Lipowski E, Segal R, Kimberlin C, Algina J.
Physicians’ intent to comply with the American Medical Association’s guidelines on gifts from the pharmaceutical industry
Journal of Medical Ethics 2007 June 1;33:(6):313-319
http://jme.bmj.com/cgi/content/full/33/6/313

HSL10313
Arnst C.
The High Cost of the Diabetes Controversy
BusinessWeek 2007 June 1
http://www.businessweek.com/bwdaily/dnflash/content/jun2007/db20070601_501893.htm

HSL10944
No authors listed
HIV and gender. Women fail to question effects of drugs on genders.
AIDS Policy Law 2007 Jun 1;22:(11):5
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17619276&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL10945
No authors listed
Clinton challenges drugmakers' stand on generic AIDS drugs.
AIDS Policy Law. 2007 June 1;22:(11):2
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17619273&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL10957
Wilan KH.
Opening up the Ivory Tower.
Cell 2007 Jun 1;129:(5):847-50
http://linkinghub.elsevier.com/retrieve/pii/S0092-8674(07)00671-X

HSL10958
Jackson CW, Sheehan AH, Reddan JG.
Evidence-based review of the black-box warning for droperidol.
Am J Health Syst Pharm 2007 Jun 1;64:(11):1174-86
http://www.ajhp.org/cgi/content/full/64/11/1174

HSL10959
Young D.
FDA mulls over paperless labeling.
Am J Health Syst Pharm 2007 Jun 1;64:(11):1120,
http://www.ajhp.org/cgi/content/full/64/11/1120

HSL11325
Schneider N, Lingner H, Schwartz FW.
Disclosing conflicts of interest in German publications concerning health services research.
BMC Health Serv Res 2007 Jun 1;7:78
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17543111

HSL11711
Faunce TA, Lexchin J.
'Linkage' pharmaceutical evergreening in Canada and Australia.
Aust New Zealand Health Policy 2007 Jun 1;4:(1):8
http://www.anzhealthpolicy.com/content/4/1/8

HSL10123
Schramm J, Andersen M, Vach K, Kragstrup J, Kampmann JP, Sondergaard J.
Promotional methods used by representatives of drug companies: A prospective survey in general practice.
Scand J Prim Health Care 2007 Jun;25:(2):93-7
http://www.informaworld.com/smpp/content?content=10.1080/02813430701339659

HSL10224
Block AE.
Costs and Benefits of Direct-to-Consumer Advertising: The Case of Depression.
Pharmacoeconomics 2007 June;25:(6):511-21
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17523755&query_hl=2&itool=pubmed_DocSum

HSL10294
Roughead EE, Anderson B, Gilbert AL.
Potentially inappropriate prescribing among Australian veterans and war widows/widowers.
Intern Med J 2007 Jun;37:(6):402-5
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17535384

HSL10298
Gellad ZF, Lyles KW.
Direct-to-consumer advertising of pharmaceuticals.
Am J Med 2007 Jun;120:(6):475-80
http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(06)01265-4

HSL10393
Cassels A.
Is the pharmaceutical industry immoral, dishonest, corrupt?
Common Ground 2007 Jun
http://commonground.ca/iss/0706191/cg191_pharma.shtml

HSL10563
Millard WB.
Docking the tail that wags the dog: banning drug reps from academic medical facilities.
Ann Emerg Med 2007 Jun;49:(6):785-91
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17536244&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL10603
Wager E
Medical Writers and Peer-Reviewed Journals: Understanding the Rules and Responsibilities.
: Keyword Pharma Expert Reviews 2007 Jun
http://www.keywordpharma.com/medicalwriters/

HSL10680
Novack GD.
The role of pharmaceutical companies in sponsored research.
Ophthalmology 2007 Jun;114:(6):1037-8
http://linkinghub.elsevier.com/retrieve/pii/S0161-6420(07)00216-3

HSL10736
Wynia MK.
Public health, public trust and lobbying.
Am J Bioeth 2007 Jun;7:(6):4-7
http://www.informaworld.com/smpp/content?content=10.1080/15265160701429599

HSL10768
Williams J, Klinepeter K, Palmes G, Pulley A, Meschan Foy J.
Behavioral health practices in the midst of black box warnings and mental health reform.
Clin Pediatr (Phila) 2007 Jun;46:(5):424-30
http://cpj.sagepub.com/cgi/reprint/46/5/424

HSL10772
Cawthorne P, Ford N, Wilson D, Kijtiwatchakul K, Purahong V, Tianudom N, Nacapew S.
Access to drugs: the case of Abbott in Thailand.
Lancet Infect Dis 2007 Jun;7:(6):373-4
http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(07)70118-4

HSL10774
MacLennan AH, Sturdee DW.
Time for evidence-based labelling of over-the-counter medicines.
Climacteric 2007 Jun;10:(3):179-80
http://www.informaworld.com/smpp/content?content=10.1080/13697130701371508

HSL10826
Nemoto K, Tachikawa H, Sodeyama N, Endo G, Hashimoto K, Mizukami K, Asada T.
Quality of Internet information referring to mental health and mental disorders in Japan.
Psychiatry Clin Neurosci 2007 Jun;61:(3):243-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1819.2007.01650.x

HSL10831
Contiades X, Golna C, Souliotis K.
Pharmaceutical regulation in Greece at the crossroad of change: economic, political and constitutional considerations for a new regulatory paradigm.
Health Policy 2007 Jun;82:(1):116-29
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(06)00191-6

HSL10897
Griffin JW.
Academic neurology and industry: open doors or firewalls?
Nat Clin Pract Neurol 2007 Jun;3:(6):297
http://www.nature.com/ncpneuro/journal/v3/n6/full/ncpneuro0523.html;jsessionid=150EC70BA30267EA38129B428872D797

HSL10899
Gosliner W, Madsen KA.
Marketing foods and beverages: why licensed commercial characters should not be used to sell healthy products to children.
Pediatrics 2007 Jun;119:(6):1255-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17545404&dopt=Abstract

HSL10900
Jobe AH.
Drug pricing in pediatrics: the egregious example of indomethacin.
Pediatrics 2007 Jun;119:(6):1197-8
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17545388&dopt=Abstract

HSL10948
Kruszewski SP, Klotz SG.
Modafinil: mischaracterization.
J Clin Psychiatry 2007 Jun;68:(6):970-1
http://article.psychiatrist.com/loginInter.asp?ID=10003123

HSL10950
[No authors listed].
Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
Prescrire Int 2007 Jun;16:(89):126-8
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17585428&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL10969
Oswald DP, Sonenklar NA.
Medication use among children with autism spectrum disorders.
J Child Adolesc Psychopharmacol 2007 Jun;17:(3):348-55
http://www.liebertonline.com/doi/abs/10.1089/cap.2006.17303

HSL10970
Brinker A, Mosholder A, Schech SD, Burgess M, Avigan M.
Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.
J Child Adolesc Psychopharmacol 2007 Jun;17:(3):328-33
http://www.liebertonline.com/doi/abs/10.1089/cap.2006.0062

HSL10972
Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ.
Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.
Am J Psychiatry 2007 Jun;164:(6):884-91
http://ajp.psychiatryonline.org/cgi/content/full/164/6/884

HSL11006
[No authors listed].
Nothing unusual about off-label prescriptions.
Johns Hopkins Med Lett Health After 50. 2007 June;19:(4):6
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17644848&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11018
Krishna R, Schaefer HG, Bjerrum OJ.
Effective integration of systems biology, biomarkers, biosimulation, and modeling in streamlining drug development.
J Clin Pharmacol 2007 Jun;47:(6):738-43
http://jcp.sagepub.com/cgi/content/full/47/6/738

HSL11023
Ostergard DR.
Lessons from the past: directions for the future? Do new marketed surgical procedures and grafts produce ethical, personal liability, and legal concerns for physicians
Int Urogynecol J Pelvic Floor Dysfunct. 2007 June;18:(6):591-8 Epub 2007 Mar 16
http://www.springerlink.com/content/j38417833325m526/

HSL11093
Wadman M.
Mixed bag for industry as key drug act moves towards reauthorization.
Nat Rev Drug Discov 2007 Jun;6:(6):421-2
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17633786&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11094
[No authors listed].
A step in the right direction.
Nat Rev Drug Discov 2007 Jun;6:(6):419
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17633785&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11100
No authors listed.
Off-label drugs: question your doctor.
Consum Rep 2007 Jun;72:(6):47
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17632948&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11104
Lesko LJ.
Personalized medicine: elusive dream or imminent reality?
Clin Pharmacol Ther 2007 Jun;81:(6):807-16
http://www.nature.com/clpt/journal/v81/n6/abs/6100204a.html

HSL11186
Popovsky MA, Garcia N.
Industry and medicine: conflicting interests and the power of money.
Transfusion 2007 Jun;47:(6):1098-9
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1537-2995.2007.01259.x

HSL11271
[No authors listed].
Board of Dentistry says "Best Dentists" lists are violation of advertising laws and rules.
Todays FDA 2007 Jun;19:(6):27
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17712925&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11272
FDA Legal Affairs Department.
Know the do's and don'ts of dental advertising.
Todays FDA 2007 Jun;19:(6):24-5
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17712924&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11279
Riley JB Jr, Basilius PA.
Physicians' liability for off-label prescriptions.
Nephrol News Issues 2007 Jun;21:(7):43-4,
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17623984&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11281
Campo D.
Big pharma.
Del Med J 2007 Jun;79:(6):243-5
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17621870&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11283
Cong WH, Chen KJ.
FDA acknowledges TCM belonging to whole medical systems.
Chin J Integr Med 2007 Jun;13:(2):83-4
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17609901&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11284
Gleason PP, Walters C, Heaton AH, Schafer JA.
Telithromycin: the perils of hasty adoption and persistence of off-label prescribing.
J Manag Care Pharm 2007 Jun;13:(5):420-5
http://www.amcp.org/data/jmcp/JMCPMaga_June%2007_p420-425.pdf

HSL11290
Houghton IT.
The Fluotec--early advertising.
Anaesth Intensive Care 2007 Jun;35:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17595903&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11298
del Llano J.
Discussion point: should governments buy drug patents?
Eur J Health Econ 2007 Jun;8:(2):173-7
http://www.springerlink.com/content/j08718r186082091/

HSL11358
Kreimer S.
Patient safety. Fragmented care heightens error risk for surgical patients
Hosp Health Netw. 2007 Jun;81:(6):32
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17695162&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11369
Thomson A.
The role of marketing in transplantation.
Prog Transplant 2007 Jun;17:(2):85-8
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17624129&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11370
Geier GR.
Professionalism, ethics, and trust.
Minn Med 2007 Jun;90:(6):20
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17621915&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11416
Brixner DI, Joish VN, Odera GM, Avey SG, Hanson DM, Cannon HE.
Effects of benefit design change across 5 disease states.
Am J Manag Care 2007 Jun;13:(6):
http://www.ajmc.com/files/articlefiles/AJMC_07junPrt2_Brixner370to76.pdf

HSL11417
Gilman BH, Kautter J.
Consumer response to dual incentives under multitiered prescription drug formularies.
Am J Manag Care 2007 Jun;13:(6):
http://www.ajmc.com/files/articlefiles/AJMC_07junPrt2Gilman353to59.pdf

HSL11418
Kephart G, Skedgel C, Sketris I, Grootendorst P, Hoar J.
Effect of copayments on drug use in the presence of annual payment limits.
Am J Manag Care 2007 Jun;13:(6):
http://www.ajmc.com/files/articlefiles/AJMC07junPrt2_Kephart328to34.pdf

HSL11429
Critical Appraisal of Drug Advertising
Best Practice Journal 2007 Jun;(6):28-31
http://www.bpac.org.nz/magazine/2007/june/drugs.asp

HSL11451
Powers P.
Persuasion and coercion: a critical review of philosophical and empirical approaches.
HEC Forum 2007 Jun;19:(2):125-43
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17694994&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL11528
Bawa R.
Patents and nanomedicine.
Nanomed 2007 Jun;2:(3):351-74
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17716180

Page 82 of 206 pages ‹ First  < 80 81 82 83 84 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909